Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 222-233

  Tremblay, Pierrot ^a   Beaudet, Marie Josée ^a   Tremblay, Eve ^a   Rueda, Naika ^a   Thomas, Tina ^b   Vallières, Luc ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

angiogenesis; blood vessels; glioblastomas; gliomas; vascular cooption

Indexed keywords

GELATINASE A; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA CELL; BRAIN TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; TUMOR GROWTH;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 79955810316     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2854     Document Type: Article

References (40)

1. Gilbertson RJ, Rich JN, Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nature Rev Cancer 2007; 7: 733-736. (Pubitemid 47463683)
2. Farin A, Suzuki SO, Weiker M, et al., Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006; 53: 799-808.
3. Fischer I, Gagner JP, Law M, et al., Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 2005; 15: 297-310. (Pubitemid 41677429)
4. Jain RK, di Tomaso E, Duda DG, et al., Angiogenesis in brain tumours. Nature Rev Neurosci 2007; 8: 610-622. (Pubitemid 47093931)
5. Villeneuve J, Galarneau H, Beaudet MJ, et al., Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment. Brain Pathol 2008; 18: 401-414. (Pubitemid 351782849)
6. Parks WC, Wilson CL, Lopez-Boado YS,. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Rev Immunol 2004; 4: 617-629. (Pubitemid 39025047)
7. Strongin AY, Collier I, Bannikov G, et al., Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331-5338.
8. Bjorklund M, Koivunen E,. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005; 1755: 37-69. (Pubitemid 40720240)
9. Dean RA, Overall CM,. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics 2007; 6: 611-623. (Pubitemid 46630094)
10. van Hinsbergh VW, Koolwijk P,. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 2008; 78: 203-212. (Pubitemid 351556093)
11. Santos-Martinez MJ, Medina C, Jurasz P, et al., Role of metalloproteinases in platelet function. Thromb Res 2008; 121: 535-542. (Pubitemid 351174273)
12. Rao JS, Steck PA, Mohanam S, et al., Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Res 1993; 53: 2208-2211. (Pubitemid 23156800)
13. Nakagawa T, Kubota T, Kabuto M, et al., Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77. (Pubitemid 24195510)
14. Sawaya RE, Yamamoto M, Gokaslan ZL, et al., Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metastasis 1996; 14: 35-42. (Pubitemid 26009753)
15. Lampert K, Machein U, Machein MR, et al., Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 1998; 153: 429-437. (Pubitemid 28373654)
16. Forsyth PA, Laing TD, Gibson AW, et al., High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. J Neurooncol 1998; 36: 21-29. (Pubitemid 28230649)
17. Pagenstecher A, Wussler EM, Opdenakker G, et al., Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors. J Neuropathol Exp Neurol 2001; 60: 598-612. (Pubitemid 32523624)
18. Kunishio K, Okada M, Matsumoto Y, et al., Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 2003; 20: 39-45. (Pubitemid 38146269)
19. Wang M, Wang T, Liu S, et al., The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 2003; 20: 65-72. (Pubitemid 38146273)
20. Komatsu K, Nakanishi Y, Nemoto N, et al., Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 2004; 21: 105-112. (Pubitemid 40187984)
21. Nakano A, Tani E, Miyazaki K, et al., Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 1995; 83: 298-307.
22. Beliveau R, Delbecchi L, Beaulieu E, et al., Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Ann N Y Acad Sci 1999; 886: 236-239. (Pubitemid 30042447)
23. VanMeter TE, Rooprai HK, Kibble MM, et al., The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 2001; 53: 213-235. (Pubitemid 33034693)
24. Wild-Bode C, Weller M, Wick W,. Molecular determinants of glioma cell migration and invasion. J Neurosurg 2001; 94: 978-984. (Pubitemid 32799599)
25. Rao JS, Steck PA, Tofilon P, et al., Role of plasminogen activator and of 92-kDa type IV collagenase in glioblastoma invasion using an in vitro Matrigel model. J Neurooncol 1994; 18: 129-138. (Pubitemid 24216048)
26. Uhm JH, Dooley NP, Villemure JG, et al., Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 1996; 14: 421-433. (Pubitemid 26365119)
27. Deryugina EI, Luo GX, Reisfeld RA, et al., Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 1997; 17: 3201-3210. (Pubitemid 27522271)
28. Sarkar S, Yong VW,. Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix. J Neurooncol 2009; 91: 157-164.
29. Price A, Shi Q, Morris D, et al., Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340. Clin Cancer Res 1999; 5: 845-854. (Pubitemid 29180837)
30. Takahashi M, Fukami S, Iwata N, et al., In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture. Pharmacol Res 2002; 46: 155-163. (Pubitemid 35300779)
31. Lee MT, Coburn GA, McClure MO, et al., Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003; 77: 11964-11972. (Pubitemid 37339850)
32. Watson DJ, Kobinger GP, Passini MA, et al., Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 2002; 5: 528-537. (Pubitemid 34546082)
33. Vallieres L, Sawchenko PE,. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003; 23: 5197-5207. (Pubitemid 36793248)
34. Villeneuve J, Tremblay P, Vallieres L,. Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation. Cancer Res 2005; 65: 3928-3936. (Pubitemid 40616375)
35. Hynes RO,. The extracellular matrix: not just pretty fibrils. Science 2009; 326: 1216-1219.
36. Galarneau H, Villeneuve J, Gowing G, et al., Increased glioma growth in mice depleted of macrophages. Cancer Res 2007; 67: 8874-8881. (Pubitemid 47437464)
37. Du R, Petritsch C, Lu K, et al., Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol 2008; 10: 254-264.
38. Kargiotis O, Chetty C, Gondi CS, et al., Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 2008; 27: 4830-4840.
39. Oliver L, Olivier C, Marhuenda FB, et al., Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2009; 2: 263-284.
40. Amberger-Murphy V,. Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 2009; 9: 381-390.